tiprankstipranks
BELLUS Health (GB:0A4U)
LSE:0A4U

BELLUS Health (0A4U) Income Statement

0 Followers

BELLUS Health Income Statement

Last quarter (Q ), BELLUS Health's total revenue was $3.00K, a decrease of -25.00% from the same quarter last year. In Q, BELLUS Health's net income was $-25.06M. See BELLUS Health’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 11.00K$ 16.00K$ 16.00K$ 15.00K$ 27.00K$ 25.70K
Cost of Revenue
------
Gross Profit
$ 7.00K$ 16.00K----
Operating Expense
$ 66.99M$ 77.90M$ 73.30M$ 32.96M$ 25.76M$ 7.30M
Operating Income
$ -66.98M$ -77.88M$ -73.28M$ -32.94M$ -25.73M$ -7.27M
Net Non Operating Interest Income Expense
$ 5.73M$ 4.74M$ 178.00K$ 1.01M$ 1.12M$ 262.11K
Other Income Expense
$ -782.00K-$ 1.68M$ 179.00K$ -1.40M$ 341.40K
Pretax Income
$ -62.00M$ -76.02M$ -71.42M$ -31.76M$ -26.01M$ -6.67M
Tax Provision
$ 79.00K$ 60.00K$ -199.00K$ 0.00-$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -62.08M$ -76.08M$ -71.22M$ -31.76M$ -26.01M$ -6.67M
Basic EPS
$ -0.53$ -0.66$ -0.90$ -0.54$ -0.56$ -0.20
Diluted EPS
$ -0.60$ -0.66$ -0.90$ -0.54$ -0.56$ -0.20
Basic Average Shares
$ 348.70M$ 115.36M$ 79.32M$ 59.02M$ 47.43M$ 33.62M
Diluted Average Shares
$ 348.70M$ 115.36M$ 79.32M$ 59.02M$ 47.43M$ 33.62M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 66.99M$ 77.90M$ 73.30M$ 32.96M$ 25.76M$ 7.30M
Net Income From Continuing And Discontinued Operation
$ -62.08M$ -76.08M$ -71.22M$ -31.76M$ -26.01M$ -6.67M
Normalized Income
$ -18.00M-$ -72.90M$ -31.94M$ -24.61M$ -6.95M
Interest Expense
$ 15.00K-$ 55.00K$ 39.00K$ 23.00K$ 3.67K
EBIT
$ -67.33M$ -80.76M$ -71.37M$ -31.72M$ -25.98M$ -6.67M
EBITDA
$ -18.65M-$ -71.17M$ -31.54M$ -25.87M$ -6.67M
Currency in USD

BELLUS Health Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis